WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage ... late-stage trials that will track patients over a longer period of time and, if successful, be submitted for FDA approval. “It’s ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback